Few people with heart failure take guideline-recommended drug
DCRI researchers found that heart failure patients are much more likely to take a guideline-recommended medication if they are started on the drug while still in the hospital.
Study finds lower death rates for TAVR centers that do more procedures
The findings could inform a CMS decision on volume as a criterion for Medicare coverage.
Lack of physician guidance, fear of side effects lead to lower statin adherence
Despite national guidelines indicating that statins can lower risk of heart attack and stroke, many patients who could benefit do not take them.
Large accountable care organizations committed to overhauled Medicare program
ACC 2019: 12-month results show ticagrelor safe in STEMI patients treated with thrombolysis
ACC 2019: Use of guideline-directed medical therapies for comorbidities may improve outcomes for patients with atrial fibrillation
Although nearly two-thirds of the study population did not receive all the guideline-directed medical therapies for which they were eligible, use of all therapies was linked to better outcomes in s
ACC 2019: Some heart disease, AF patients on combined therapies could skip aspirin
Data show bleeding risk from aspirin could outweigh protection from another heart event.
ACC 2019: Study confirms diagnostic accuracy of non-invasive technology for heart pain
Compound improves heart failure biomarker even after hospitalization
A new study shows sacubitril/valsartan can still improve heart stress if prescribed later.
ACC 2019: A multidisciplinary approach to improve care for geriatric heart failure patients
Care for older adults with heart failure can be optimized using a four-domain framework including medical, mind, physical function, and social environment.